Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53443, first published .
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study

Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study

Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study

Maria A Lopez-Olivo   1 , MD, PhD ;   Maria E Suarez-Almazor   1, 2 , MD, PhD ;   Gabrielle F Duhon   3 , MPH ;   McKenna Cherry   4 , BS ;   Huifang Lu   2 , MD, PhD ;   Cassandra Calabrese   5 , DO ;   Mehmet Altan   6 , MD ;   Hussain Tawbi   7 , MD, PhD ;   Alexa Meara   8 , MD ;   Clifton O Bingham   9 , MD ;   Adi Diab   7 , MD ;   Viola B Leal   1 , MPH ;   Robert J Volk   1 , PhD

1 Department of Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States

2 Section of Rheumatology and Clinical Immunology of the Department of General Internal Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States

3 OCHIN, Inc, Portland, OR, United States

4 Texas Woman's University, Houston, TX, United States

5 Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, TX, United States

6 Department of Thoracic-Head & Neck Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States

7 Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States

8 Division of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, United States

9 Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States

Corresponding Author:

  • Maria A Lopez-Olivo, MD, PhD
  • Department of Health Services Research
  • MD Anderson Cancer Center
  • The University of Texas
  • 1515 Holcombe Boulevard
  • Houston, TX, TX 77030
  • United States
  • Phone: 1 7135630020
  • Email: amlopezo@mdanderson.org